SFRE was found to reduce the expression of PD-L1 and CX3CRl, which exert immunosuppressive effects in the tumor microenvironment, suggesting that SFRE may contribute to the reduction of immune evasion by lung cancer cells (86). The gene discussed is CD274; the disease is neoplasm.